[1]BRINDLEY PJ,BACHINI M,ILYAS SI,et al.Cholangiocarcinoma[J].Nat Rev Dis Primers,2021,7(1):65.
[2]ITO F,CHO CS,RIKKERS LF,et al.Hilar cholangiocarcinoma:current management [J].Ann Surg,2009,250(2):210-218.
[3]SAPISOCHIN G,IVANICS T,SUBRAMANIAN V,et al.Multidisciplinary treatment for hilar and intrahepatic cholangiocarcinoma:A review of the general principles [J].Int J Surg,2020,82S:77-81.
[4]ZHONG W,DONG S,WANG H,et al.Functional mechanism of MicroRNA-25-3p in hilar cholangiocarcinoma cell proliferation and migration through regulation of dual specificity phosphatase 5 [J].J Invest Surg,2023,36(1):2202768.
[5]WANG Z,LI TE,CHEN M,et al.miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway [J].Aging(Albany NY),2020,12(2):1867-1887.
[6]SUN J,DENG L,GONG Y.MiR-145-5p inhibits the invasion of prostate cancer and induces apoptosis by inhibiting WIP1 [J].J Oncol,2021,2021:4412705.
[7]TANG C,YUAN P,WANG J,et al.MiR-192-5p regulates the proliferation and apoptosis of cholangiocarcinoma cells by activating MEK/ERK pathway [J].Biotech,2021,11(2):99.
[8]WAN P,CHI X,DU Q,et al.miR-383 promotes cholangiocarcinoma cell proliferation,migration,and invasion through targeting IRF1 [J].J Cell Biochem,2018,119(12):9720-9729.
[9]CHEN H,LI Z,ZHANG L,et al.MicroRNA-200c inhibits the metastasis of triple-negative breast cancer by targeting ZEB2,an epithelial-mesenchymal transition regulator [J].Ann Clin Lab Sci,2020,50(4):519-527.
[10]MERVE M,UMAR R,OZGE S,et al.miR-200c:a versatile watchdog in cancer progression,EMT,and drug resistance [J].J Mol Med,2016,94(6):629-644.
[11]WANG F,ZHANG L,XU H,et al.The significance role of microRNA-200c as a prognostic factor in various human solid malignant neoplasms:A Meta-analysis [J].J Cancer,2019,10(1):277-286.
[12]ZHUO M,YUAN CC,HAN T,et al.A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis [J].BMC Cancer,2018,18(2):1032-1039.
[13]ZHANG HC,SUN ZG,LI Y,et al.MicroRNA-200c binding to FN1 suppresses the proliferation,migration and invasion of gastric cancer cells [J].Biomed Pharmacother,2017,88(6):285-292.
[14]SMITH CM,WATSON DI,LEONG MP,et al.miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus [J].World J Gastroenterol,2011,17(8):1036-1044.
[15]YEH TS,WANG F,CHEN TC,et al.Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus [J].Ann Surg,2014,259(2):346-354.
[16]PARK M,KIM D,KO S,et al.Breast cancer metastasis:Mechanisms and therapeutic implications [J].Int J Mol Sci,2022,23(12):6806.
[17]NAVHIYAPPAN A,GUPTA N,TANEJA R.EHMT1/EHMT2 in EMT,cancer stemness and drug resistance:emerging evidence and mechanisms [J].FEBS J,2022,289(5):1329-1351.
[18]KIM HK,YANG Y,BYEON S,et al.E-cadherin and angiopoietin-2 as potential biomarkers for colorectal cancer with peritoneal carcinomatosis [J].Anticancer Res,2021,41(9):4497-4504.
[19]王思念,吕进,张巧云,等.miRNA与肿瘤侵袭转移 [J].现代肿瘤医学,2016,24(03):485-487.
WANG SN,LYU J,ZHANG QY,et al.miRNA and invasion and metastasis of cancer[J].Modern Oncology,2016,24(03):485-487.
[20]OTAKE S,ITOH Y,OMATA C,et al.ZEB1 and oncogenic Ras constitute a regulatory switch for stimulus-dependent E-cadherin downregulation [J].Cancer Sci,2021,112(1):205-216.
[21]MUNOZ-HIDALGO L,SAN-MIGUEL T,MEGIAS J,et al.The status of EGFR modulates the effect of miRNA-200c on ZEB1 expression and cell migration in glioblastoma cells [J].Int J Mol Sci,2020,22(1):368.
[22]CHEN Y,SUN Y,CHEN L,et al.miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling [J].Mol Med Rep,2013,7(5):1579-1584.
[23]LAI YH,LIU WL,LEE TY,et al.Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo [J].Phytomedicine,2023,110:154597.